Thank you, Mr. Chair.
Mr. Letarte, we heard that the bill doesn't clearly identify what qualifies as an adverse effect, particularly when it comes to exempting an organization with a legitimate interest from the need to obtain an individual's consent to collect, use and share their data.
In your expert opinion, how should the bill clarify this provision on adverse effects, and how could this ambiguity affect privacy?